Major trial looks at most effective speech therapy for people with Parkinson’s disease

A major clinical trial, led by researchers at the University of Nottingham, has shown the Lee Silverman Voice Treatment (LSVT LOUD) is more effective than the current speech and language therapy provided by the NHS, when treating patients with Parkinson’s disease (PD). The results of the trial, which are published today in The BMJ, showed that LSVT LOUD was more effective at reducing the participant’s reported impact of voice problems than no speech and language therapy, as well as the NHS delivered speech and language therapy. The trial was led Read More

Related posts:

  1. Cholesterol-lowering drug slows progression of eye disease in people with diabetes: Clinical trial
  2. Music therapy helps stroke survivors regain lost speech by singing
  3. Study finds major hearing difficulties in people over 90
  4. Trained peers are as effective as clinical social workers in reducing opioid overdose, new trial finds
  5. New AI program analyzing speech patterns could predict likelihood of Alzheimer’s disease
  6. Semaglutide found to cut major adverse cardiovascular events in people with overweight, obesity
  7. Antibody-drug conjugate highly effective in preventing recurrence in early stage HER2+ breast cancer, trial finds
  8. Scientists uncover novel major risk gene for autoimmune thyroid disease

Leave a Reply

Your email address will not be published. Required fields are marked *